{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:56:34Z","timestamp":1767866194847,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,12,20]],"date-time":"2014-12-20T00:00:00Z","timestamp":1419033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s00432-014-1892-z","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T17:09:57Z","timestamp":1419008997000},"page":"1221-1235","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Anti-LeY antibody enhances therapeutic efficacy of celecoxib against gastric cancer by downregulation of MAPKs\/COX-2 signaling pathway: correlation with clinical study"],"prefix":"10.1007","volume":"141","author":[{"given":"Faisal","family":"Aziz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuesong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,20]]},"reference":[{"key":"1892_CR1","first-page":"411","volume":"30","author":"F Aziz","year":"2013","unstructured":"Aziz F, Yang X, Wang X, Qiu Y (2013) Helicobacter pylori infection leads to gastric cancer with the coexpression of Lewis Y and CA724. Glycoconj J 30:411 (abstract)","journal-title":"Glycoconj J"},{"issue":"1","key":"1892_CR2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11274-013-1448-4","volume":"30","author":"F Aziz","year":"2014","unstructured":"Aziz F, Sherwani SK, Akhtar SS, Kazmi SU (2014a) Development of an in-house enzyme linked immunosorbent assay based on surface whole cell antigen for diagnosis of Helicobacter pylori infection in patients with gastroduodenal ulcer disease. World J Microbiol Biotechnol 30(1):305\u2013315","journal-title":"World J Microbiol Biotechnol"},{"key":"1892_CR3","doi-asserted-by":"crossref","unstructured":"Aziz F, Yang X, Qingping W, Qiu Y (2014b) A method for establishing human primary gastric epithelial cell culture from fresh surgical gastric tissue. Mol Med Rep [Epub ahead of print]","DOI":"10.3892\/mmr.2015.3692"},{"issue":"42","key":"1892_CR4","doi-asserted-by":"crossref","first-page":"7361","DOI":"10.3748\/wjg.v19.i42.7361","volume":"19","author":"J Cheng","year":"2013","unstructured":"Cheng J, Fan XM (2013) Role of cyclooxygenase-2 in gastric cancer development and progression. World J Gastroenterol 19(42):7361\u20137368","journal-title":"World J Gastroenterol"},{"issue":"17","key":"1892_CR5","first-page":"4804","volume":"60","author":"K Clarke","year":"2000","unstructured":"Clarke K, Lee FT, Brechbiel MW, Smyth FE, Old LJ, Scott AM (2000a) In vivo bio distribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB\/c nude mice. Cancer Res 60(17):4804\u20134811","journal-title":"Cancer Res"},{"issue":"9","key":"1892_CR6","first-page":"3621","volume":"6","author":"K Clarke","year":"2000","unstructured":"Clarke K, Lee FT, Brechbiel MW, Smyth FE, Old LJ, Scott AM (2000b) Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy. Clin Cancer Res 6(9):3621\u20133628","journal-title":"Clin Cancer Res"},{"issue":"5","key":"1892_CR7","first-page":"1118","volume":"56","author":"MS Co","year":"1996","unstructured":"Co MS, Baker J, Bednarik K, Janzek E, Neruda W, Mayer P, Plot R, Stumper B, Vasquez M, Queen C, Loibner H (1996) Humanized anti-Lewis Y antibodies: in vitro properties and pharmacokinetics in rhesus monkeys. Cancer Res 56(5):1118\u20131125","journal-title":"Cancer Res"},{"issue":"5","key":"1892_CR8","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1053\/gast.2002.36558","volume":"123","author":"S Fiorucci","year":"2002","unstructured":"Fiorucci S, de Lima OM, Mencarelli A Jr, Palazzetti B, Distrutti E, McKnight W, Dicay M, Ma L, Romano M, Morelli A, Wallace JL (2002) Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage. Gastroenterology 123(5):1598\u20131606","journal-title":"Gastroenterology"},{"issue":"11","key":"1892_CR9","first-page":"2554","volume":"6","author":"M Geng","year":"2013","unstructured":"Geng M, Wang L, Li P (2013) Correlation between chemosensitivity to anticancer drugs and Bcl-2 expression in gastric cancer. Int J Clin Exp Pathol 6(11):2554\u20132559","journal-title":"Int J Clin Exp Pathol"},{"issue":"6","key":"1892_CR10","doi-asserted-by":"crossref","first-page":"e38353","DOI":"10.1371\/journal.pone.0038353","volume":"7","author":"J Gomes","year":"2012","unstructured":"Gomes J, Magalh\u00e3es A, Carvalho AS, Hernandez GE, Papp SL, Head SR, Michel V, David L, G\u00e4rtner F, Touati E, Reis CA (2012) Glycophenotypic alterations induced by Pteridium aquilinum in mice gastric mucosa: synergistic effect with Helicobacter pylori infection. PLoS One 7(6):e38353","journal-title":"PLoS One"},{"issue":"6","key":"1892_CR11","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3109\/s10165-012-0819-2","volume":"23","author":"M Hasegawa","year":"2013","unstructured":"Hasegawa M, Horiki N, Tanaka K, Wakabayashi H, Tano S, Katsurahara M, Uchida A, Takei Y, Sudo A (2013) The efficacy of rebamipide add on therapy in arthritic patients with COX-2 selective inhibitor-related gastrointestinal events: a prospective, randomized, open-label blinded-endpoint pilot study by the GLORIA study group. Mod Rheumatol 23(6):1172\u20131178","journal-title":"Mod Rheumatol"},{"issue":"2","key":"1892_CR12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/gut.2003.021477","volume":"53","author":"PJ Hu","year":"2004","unstructured":"Hu PJ, Yu J, Zeng ZR, Leung WK, Lin HL, Tang BD, Bai AH, Sung JJ (2004) Chemoprevention of gastric cancer by celecoxib in rats. Gut 53(2):195\u2013200","journal-title":"Gut"},{"issue":"1","key":"1892_CR13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s10147-011-0354-8","volume":"18","author":"S Kaneko","year":"2013","unstructured":"Kaneko S, Kaneko M, Fukushima T (2013) Enhanced antitumor effect of lower-dose and longer-term CPT-11 treatment in combination with low-dose celecoxib against neuroblastoma xenografts. Int J Clin Oncol 18(1):116\u2013125","journal-title":"Int J Clin Oncol"},{"issue":"4","key":"1892_CR14","first-page":"716","volume":"47","author":"MP Kelly","year":"2006","unstructured":"Kelly MP, Lee FT, Smyth FE, Brechbiel MW, Scott AM (2006) Enhanced efficacy of 90Y radiolabelled anti-Lewis Y humanized monoclonal antibody hu3S193 and Palictaxel combined-modality radioimmunotherapy in a breast cancer model. J Nucl Med 47(4):716\u2013725","journal-title":"J Nucl Med"},{"issue":"18 Pt 2","key":"1892_CR15","doi-asserted-by":"crossref","first-page":"5604s","DOI":"10.1158\/1078-0432.CCR-07-1071","volume":"13","author":"MP Kelly","year":"2007","unstructured":"Kelly MP, Lee FT, Tahtis K, Smyth FE, Brechbiel MW, Scott AM (2007) Radioimmunotherapy with alpha-particle emitting 213Bi-C-functionalized trans-cyclohexyl-diethylenetriaminepentaacetic acid-humanized 3S193 in enhanced by combination with pclitaxel chemotherapy. Clin Cancer Res 13(18 Pt 2):5604s\u20135612s","journal-title":"Clin Cancer Res"},{"key":"1892_CR16","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1177\/002215540004801211","volume":"48","author":"N Kovacic","year":"2000","unstructured":"Kovacic N, Muthing J, Marusic A (2000) Immunohistological and flow cytometric analysis of glycosphingolipid expression in mouse lymphoid tissues. J Histochem Cytochem 48:1677\u20131690","journal-title":"J Histochem Cytochem"},{"issue":"19 Pt 2","key":"1892_CR17","first-page":"7080s","volume":"11","author":"FT Lee","year":"2005","unstructured":"Lee FT, Mountain AJ, Kelly MP, Hall C, Rigopoulos A, Johns TG, Smyth FE, Brechbiel MW, Nice EC, Burgess AW, Scott AM (2005) Enhanced efficacy of radioimmunotherapy with 90YA\u2019\u2019\u2014DPTA-hu3S193 by inhibition of epidermal growth factor receptor (EGFR) signaling with EGFR tyrosine kinase inhibitor AG1478. Clin Cancer Res 11(19 Pt 2):7080s\u20137086s","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1892_CR18","first-page":"267","volume":"24","author":"FF Li","year":"2008","unstructured":"Li FF, Lin B, Hao YY, Liu JJ, Zhang F, Zhang SL (2008) Inhibitory effect of anti-Lewis y antibody on alpha1, 2-fucosyltransferase gene transfected human ovarian cancer cells in vitro. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 24(3):267\u2013269 (in Chinese)","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"issue":"39","key":"1892_CR19","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.3748\/wjg.v17.i39.4421","volume":"17","author":"Y Lin","year":"2011","unstructured":"Lin Y, Ueda J, Kikuchi S, Totsuka Y, Wei WQ, Qiao YL, Inoue M (2011) Comparative epidemiology of gastric cancer between Japan and China. World J Gastroenterol 17(39):4421\u20134428","journal-title":"World J Gastroenterol"},{"key":"1892_CR20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1756-9966-28-154","volume":"28","author":"J Liu","year":"2009","unstructured":"Liu J, Lin B, Hao Y, Qi Y, Zhu L, Li F, Liu D, Cong J, Zhang S, Iwamori M (2009) Lewis Y antigen promotes the proliferation of ovarian carcinoma-derived RMG-I cells through the P13K\/Akt signaling pathway. J Exp Clin Cancer Res 28:154","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"1892_CR21","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1021\/pr201014h","volume":"11","author":"H Loei","year":"2012","unstructured":"Loei H, Tan HT, Lim TK, Lim KH, So JB, Yeoh KG, Chung MC (2012) Mining the gastric cancer secretome: identification of GRN as potential diagnostic marker for early gastric cancer. J Proteome Res 11(3):1759\u20131772","journal-title":"J Proteome Res"},{"key":"1892_CR22","first-page":"259","volume":"28","author":"B Mahmut","year":"1998","unstructured":"Mahmut B, Ahmet K, Fatih A, Cemal G, Ibrahim K, Durkaya O (1998) Increased serum CA 72-4 levels in patients with gastrointestinal carcinoma. J Med Sci 28:259\u2013263","journal-title":"J Med Sci"},{"issue":"18","key":"1892_CR23","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.2165\/11208240-000000000-00000","volume":"71","author":"PL McCormack","year":"2011","unstructured":"McCormack PL (2011) Celecoxib. A review of its use for symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. Drugs 71(18):2457\u20132489","journal-title":"Drugs"},{"key":"1892_CR24","first-page":"725","volume":"14","author":"E Miyoshi","year":"2008","unstructured":"Miyoshi E, Moriwaki K, Nakagawa T (2008) Biological function of fucosylation in cancer biology. J Biochem 14:725\u2013729","journal-title":"J Biochem"},{"key":"1892_CR25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4254\/wjh.v2.i4.151","volume":"2","author":"K Moriwaki","year":"2010","unstructured":"Moriwaki K, Miyoshi E (2010) Fucosylation and gastrointestinal cancer. World J Hepatol 2:151\u2013161","journal-title":"World J Hepatol"},{"issue":"3","key":"1892_CR26","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1582-4934.2011.01329.x","volume":"16","author":"S Patel","year":"2012","unstructured":"Patel S, Vetale S, Teli P, Mistry R, Chiplunkar S (2012) IL-10 production in non-small cell lung carcinoma patients is regulated by ERK, P38 and COX-2. J Cell Mol Med 16(3):531\u2013544","journal-title":"J Cell Mol Med"},{"key":"1892_CR27","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ijc.20226","volume":"110","author":"GD Peluffo","year":"2004","unstructured":"Peluffo GD, Stillitani I, Rodriguez VA, Diament MJ, Klein SM (2004) Reduction of tumor progression and paraneoplastic syndrome development in murine lung adenocarcinoma by nonsteroidal anti-inflammatory drugs. Int J Cancer 110:825\u2013830","journal-title":"Int J Cancer"},{"issue":"1","key":"1892_CR28","first-page":"165","volume":"62","author":"CV Rao","year":"2002","unstructured":"Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS (2002) Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res 62(1):165\u2013170","journal-title":"Cancer Res"},{"issue":"20","key":"1892_CR29","doi-asserted-by":"crossref","first-page":"8175","DOI":"10.1158\/0008-5472.CAN-09-1377","volume":"69","author":"CV Rao","year":"2009","unstructured":"Rao CV, Steele VE, Swamy MV, Patlolla JM, Guruswamy S, Kopelovich L (2009) Inhibition of azoxymethane-induced colorectal cancer by CP-31398, a TP53 modulator, alone or in combination with low doses of celecoxib in male F344 rats. Cancer Res 69(20):8175\u20138182","journal-title":"Cancer Res"},{"issue":"4","key":"1892_CR30","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/jcp.2009.071035","volume":"63","author":"CA Reis","year":"2010","unstructured":"Reis CA, Osorio H, Silva L, Gomes C, David L (2010) Alteration in glycosylation as biomarkers for cancer detection. J Clin Pathol 63(4):322\u2013329","journal-title":"J Clin Pathol"},{"key":"1892_CR31","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/glycob\/cwi027","volume":"15","author":"F Santos-Silva","year":"2005","unstructured":"Santos-Silva F, Fonseca A, Caffrey T, Carvalho F, Mesquita P, Reis C, Almeida R, David L, Hollingsworth MA, Thomsen F (2005) Antigen expression in gastric carcinomas is associated with MUC1 mucin VNTR polymorphism. Glycobiology 15:511\u2013517","journal-title":"Glycobiology"},{"issue":"11","key":"1892_CR32","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1007\/s11064-013-1142-9","volume":"38","author":"GR Sareddy","year":"2013","unstructured":"Sareddy GR, Kesanakurti D, Kirti PB, Babu PP (2013) Nonsteroidal anti-inflammatory drugs diclofenac and celecoxib attenuates Wnt\/b-catenin\/Tcf signaling pathway in human glioblastoma cells. Neurochem Res 38(11):2313\u20132322","journal-title":"Neurochem Res"},{"issue":"15","key":"1892_CR33","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJMra020542","volume":"347","author":"S Suerbaum","year":"2002","unstructured":"Suerbaum S, Michetti P (2002) Helicobacter pylori infection. N Engl J Med 347(15):1175\u20131186","journal-title":"N Engl J Med"},{"issue":"4","key":"1892_CR34","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/515663","volume":"178","author":"J Torres","year":"1998","unstructured":"Torres J, Leal-Herrera Y, Perez-Perez G, Gomez A, Camorlinga-Ponce M, Cedillo-Rivera R, Tapia-Conyer R, Mu\u00f1oz O (1998) A community-based seroepidemiologic study of Helicobacter pylori infection in Mexico. J Infect Dis 178(4):1089\u20131094","journal-title":"J Infect Dis"},{"issue":"7","key":"1892_CR35","first-page":"846","volume":"16","author":"J Wang","year":"2010","unstructured":"Wang J, Wang WH, Li J, Liu FX (2010) Celecoxib inhibits Helicobacter pylori colonization related factors. World J Gastroenterol 16(7):846\u2013853","journal-title":"World J Gastroenterol"},{"issue":"11","key":"1892_CR36","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1128\/IAI.64.11.4598-4605.1996","volume":"64","author":"HP Wirth","year":"1996","unstructured":"Wirth HP, Yang M, Karita M, Blaser MJ (1996) Expression of the human cell surface glycoconjugates Lewis X and Lewis Y by the Helicobacter pylori isolates is related to CagA status. Infect Immun 64(11):4598\u20134605","journal-title":"Infect Immun"},{"issue":"6","key":"1892_CR37","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/gutjnl-2011-300154","volume":"61","author":"BC Wong","year":"2012","unstructured":"Wong BC, Zhang L, Ma JL, Pan KF, Li JY, Shen L, Liu WD, Feng GS, Zhang XD, Li J, Lu AP, Xia HH, Lam S, You WC (2012) Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions. Gut 61(6):812\u2013818","journal-title":"Gut"},{"issue":"5","key":"1892_CR38","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/ijc.23718","volume":"123","author":"H Xiao","year":"2008","unstructured":"Xiao H, Chung SY (2008) Combination regimen with statins and NSAIDs. A promising strategy for cancer chemoprevention. Int J Cancer 123(5):983\u2013990","journal-title":"Int J Cancer"},{"issue":"4","key":"1892_CR39","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2036.2006.03224.x","volume":"25","author":"HB Yang","year":"2007","unstructured":"Yang HB, Cheng HC, Sheu BS, Hung KH, Liou MF, Wu JJ (2007a) Chronic celecoxib users more often show regression of gastric intestinal metaplasia after Helicobacter pylori eradication. Aliment Pharmacol Ther 25(4):455\u2013461","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"1892_CR40","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.biocel.2007.04.024","volume":"39","author":"X Yang","year":"2007","unstructured":"Yang X, Zhang Z, Jia S, Liu Y, Wang X, Yan Q (2007b) Overexpression of fucosyltransferase IV in A431 cell line increase cell proliferation. Int J Biochem Cell Biol 39(9):1722\u20131730","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"1892_CR41","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/jcp.22250","volume":"225","author":"X Yang","year":"2010","unstructured":"Yang X, Liu S, Liu YJ, Liu JW, Liu TJ, Wang XQ, Yan Q (2010) Overexpression of fucosyltransferase IV promotes A431 cell proliferation through activating MAPK and PI3K\/Akt signaling pathways. J Cell Physiol 225(2):612\u2013619","journal-title":"J Cell Physiol"},{"issue":"6","key":"1892_CR42","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.3892\/or.2013.2796","volume":"30","author":"YW Ye","year":"2013","unstructured":"Ye YW, Hu S, Shi YQ, Zhang XF, Zhou Y, Zhao CL, Wang GJ, Wen JG, Zong H (2013) Combination of the FGFR4 inhibitor PD173074 and 5-fluorouracil reduces proliferation and promotes apoptosis in gastric cancer. Oncol Rep 30(6):2777\u20132784","journal-title":"Oncol Rep"},{"issue":"22","key":"1892_CR43","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.3748\/wjg.15.2731","volume":"15","author":"LJ Zhang","year":"2009","unstructured":"Zhang LJ, Wang SY, Huo XH, Zhu ZL, Chu JK, Ma JC, Cui DS, Gu P, Zhao ZR, Wang MW, Yu J (2009) Anti Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous of gastric lesions. World J Gastroenterol 15(22):2731\u20132738","journal-title":"World J Gastroenterol"},{"issue":"5","key":"1892_CR44","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00432-013-1381-9","volume":"139","author":"B Zhang","year":"2013","unstructured":"Zhang B, Ma X, Li Z, Gao X, Wang F, Liu L, Shen G, Sang Y, Li M, Li Y, Zhao J, Wei Y (2013) Celecoxib enhances the efficacy of 15-hydroxyprostaglandin dehydrogenase gene therapy in treating murine breast cancer. J Cancer Res Clin Oncol 139(5):797\u2013807","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"1892_CR45","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1158\/1940-6207.CAPR-09-0243","volume":"3","author":"Y Zhao","year":"2010","unstructured":"Zhao Y, Hao Y, Ji H, Fang Y, Guo Y, Sha W, Zhou Y, Pang X, Southerland WM, Califano JA, Gu X (2010) Combinational effect of salvianolic acid B with low dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo. Cancer Prev Res (Phila) 3(6):787\u2013796","journal-title":"Cancer Prev Res (Phila)"},{"key":"1892_CR46","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1158\/1078-0432.CCR-07-0242","volume":"13","author":"X Zheng","year":"2007","unstructured":"Zheng X, Cui XX, Avila GE, Huang MT, Liu Y, Patel J, Kong AN, Paulino R, Shih WJ, Lin Y, Rabson AB, Reddy BS et al (2007) Atorvastatin and celecoxib inhibit prostate PC-3 tumors in immunodeficient mice. Clin Cancer Res 13:5480\u20135487","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-014-1892-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-014-1892-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-014-1892-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T17:41:49Z","timestamp":1650822109000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-014-1892-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,20]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["1892"],"URL":"https:\/\/doi.org\/10.1007\/s00432-014-1892-z","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,20]]}}}